Theravance Biopharma, Inc. Increase (Decrease) in Prepaid Taxes
Theravance Biopharma, Inc. (TBPH) reported Increase (Decrease) in Prepaid Taxes of -$2.79 million for the 12-month period ending 2017-12-31, per its 10-K filed 2020-02-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidTaxes · last filed 2020-02-27
- Theravance Biopharma, Inc. increase (decrease) in prepaid taxes for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- Theravance Biopharma, Inc. increase (decrease) in prepaid taxes for the quarter ending 2017-09-30 was -$3.00M, a 16766.67% decline year-over-year.
- Theravance Biopharma, Inc. increase (decrease) in prepaid taxes for the quarter ending 2017-06-30 was $212.00K, a 92.71% decline year-over-year.
- Theravance Biopharma, Inc. increase (decrease) in prepaid taxes for the quarter ending 2017-03-31 was $0.00.
- Theravance Biopharma, Inc. increase (decrease) in prepaid taxes for fiscal 2017 was -$2.79M.
- Theravance Biopharma, Inc. increase (decrease) in prepaid taxes for fiscal 2016 was -$9.52M, a 174.60% decline from fiscal 2015.
- Theravance Biopharma, Inc. increase (decrease) in prepaid taxes for fiscal 2015 was $12.76M.
- Theravance Biopharma, Inc. increase (decrease) in prepaid taxes for fiscal 2014 was $0.00.
| Period end | Increase (Decrease) in Prepaid Taxes 3 month | Increase (Decrease) in Prepaid Taxes 6 month | Increase (Decrease) in Prepaid Taxes 9 month | Increase (Decrease) in Prepaid Taxes 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$3.00M derived: sum of 2 quarters · filed 2020-02-27 | -$2.79M derived: sum of 3 quarters · filed 2020-02-27 | -$2.79M 10-K · filed 2020-02-27 |
| 2017-09-30 | -$3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$2.79M derived: sum of 2 quarters · filed 2017-11-08 | -$2.79M 10-Q · filed 2017-11-08 | -$2.71M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $212.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $212.00K 10-Q · filed 2017-08-09 | $286.00K derived: sum of 3 quarters · filed 2019-02-28 | $304.00K derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-10 | $74.00K derived: sum of 2 quarters · filed 2019-02-28 | $92.00K derived: sum of 3 quarters · filed 2019-02-28 | $3.00M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $74.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $92.00K derived: sum of 2 quarters · filed 2019-02-28 | $3.00M derived: sum of 3 quarters · filed 2019-02-28 | -$9.52M 10-K · filed 2019-02-28 |
| 2016-09-30 | $18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $2.93M derived: sum of 2 quarters · filed 2017-11-08 | -$9.60M 10-Q · filed 2017-11-08 | $50.00K derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | $2.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$9.61M 10-Q · filed 2017-08-09 | $32.00K derived: sum of 3 quarters · filed 2018-02-28 | $126.00K derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | -$12.52M 10-Q · filed 2017-05-10 | -$2.88M derived: sum of 2 quarters · filed 2018-02-28 | -$2.78M derived: sum of 3 quarters · filed 2018-02-28 | $232.00K derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | $9.65M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $9.74M derived: sum of 2 quarters · filed 2018-02-28 | $12.75M derived: sum of 3 quarters · filed 2018-02-28 | $12.76M 10-K · filed 2018-02-28 |
| 2015-09-30 | $94.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $3.11M derived: sum of 2 quarters · filed 2016-11-09 | $3.12M 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $3.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $3.02M 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | $10.00K 10-Q · filed 2016-05-10 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-01 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |